I didn't hear the word "big" back then. That was from 3 years ago.

Here's the updated strategy

"The technologies developed by Amarantus has multiple development opportunities. As such, the Company intends to partner product development with leading academic institutions, research institutes, hospitals, clinics, small to large scale biotechnology, pharmaceutical, diagnostic and device companies to achieve maximum value creation for its high-value, multi-purposed discoveries. Amarantus is interested in partnering opportunities for its product candidates that will allow development of adjunct -products that will address diseases caused by poorly served biological pathways."

http://www.amarantus.com/about/partners